| Symbol |
Name |
|
ADARB1
|
adenosine deaminase, RNA-specific, B1
|
|
ANXA5
|
annexin A5
|
|
ARRB2
|
arrestin, beta 2
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
CAMK4
|
calcium/calmodulin-dependent protein kinase IV
|
|
CARTPT
|
CART prepropeptide
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNA2
|
cyclin A2
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CD8A
|
CD8a molecule
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CES1
|
carboxylesterase 1
|
|
CKS1B
|
CDC28 protein kinase regulatory subunit 1B
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
DAB1
|
Dab, reelin signal transducer, homolog 1 (Drosophila)
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DIO3
|
deiodinase, iodothyronine, type III
|
|
DRD3
|
dopamine receptor D3
|
|
EEF2
|
eukaryotic translation elongation factor 2
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GLO1
|
glyoxalase I
|
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
|
GRIK2
|
glutamate receptor, ionotropic, kainate 2
|
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
HBG2
|
hemoglobin, gamma G
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC5
|
histone deacetylase 5
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HES5
|
hes family bHLH transcription factor 5
|
|
HRH1
|
histamine receptor H1
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR2B
|
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
IFNA1
|
interferon, alpha 1
|
|
IL6
|
interleukin 6
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
JAG1
|
jagged 1
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
|
KCNA5
|
potassium channel, voltage gated shaker related subfamily A, member 5
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ3
|
potassium channel, inwardly rectifying subfamily J, member 3
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
|
KCNJ6
|
potassium channel, inwardly rectifying subfamily J, member 6
|
|
KCNK10
|
potassium channel, two pore domain subfamily K, member 10
|
|
KCNK2
|
potassium channel, two pore domain subfamily K, member 2
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MBD1
|
methyl-CpG binding domain protein 1
|
|
MC4R
|
melanocortin 4 receptor
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NGFR
|
nerve growth factor receptor
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOTCH1
|
notch 1
|
|
NPY
|
neuropeptide Y
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OXTR
|
oxytocin receptor
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PDYN
|
prodynorphin
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLCB1
|
phospholipase C, beta 1 (phosphoinositide-specific)
|
|
POMC
|
proopiomelanocortin
|
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PRL
|
prolactin
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
S100B
|
S100 calcium binding protein B
|
|
SLC17A7
|
solute carrier family 17 (vesicular glutamate transporter), member 7
|
|
SLC22A2
|
solute carrier family 22 (organic cation transporter), member 2
|
|
SLC32A1
|
solute carrier family 32 (GABA vesicular transporter), member 1
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SMAD1
|
SMAD family member 1
|
|
TNF
|
tumor necrosis factor
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
VLDLR
|
very low density lipoprotein receptor
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
